PBLS insider transaction filings
Parabilis Medicines, Inc. — 17 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-25. Screen PBLS transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 3 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 8 legs across 2 filings by 14 insiders — 744,593 shares, $16,919,551 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 3.
- Largest priced transaction: purchase of 375,000 shares @ $20.00 ($7,500,000) by Levy Guy, filed 2026-06-29.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Levy Guy — 10% owner & Soleus Private Equity Fund III, L.P. — 10% owner & Soleus Private Equity GP III, LLC — 10% owner & Soleus PE GP III, LLC — 10% owner & Soleus Capital Management, L.P. — 10% owner & Soleus GP, LLC — 10% owner & Soleus Capital Master Fund, L.P. — 10% owner & Soleus Capital, LLC — 10% owner & Soleus Capital Group, LLC — 10% owner | 1 | 2 legs · 500,000 sh · $10,000,000 | — | 2 |
| RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner & RA Capital Healthcare Fund LP — Director, 10% owner & RA Capital Nexus Fund III, L.P. — Director & Kolchinsky Peter — Director, 10% owner & Shah Rajeev M. — Director, 10% owner | 1 | 6 legs · 244,593 sh · $6,919,551 | — | — |
| Tendler Craig — Director | 1 | — | — | 1 |
Recent Form 4 filings — Parabilis Medicines, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-25 | 4 | Tendler Craig — Director | Grant/award (A): 20,294 (derivative) @ $0 | EDGAR |
| 2026-07-22 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 98,433 @ $27.13 · Purchase (P): 32,987 @ $27.72 · Purchase (P): 21,696 @ $27.96 · Purchase (P): 6,504 @ $29.17 · Purchase (P): 37,723 @ $30 · Purchase (P): 47,250 @ $29.77 | EDGAR |
| 2026-06-29 | 4 | Levy Guy — 10% owner Soleus Private Equity Fund III, L.P. — 10% owner Soleus Private Equity GP III, LLC — 10% owner Soleus PE GP III, LLC — 10% owner Soleus Capital Management, L.P. — 10% owner Soleus GP, LLC — 10% owner Soleus Capital Master Fund, L.P. — 10% owner Soleus Capital, LLC — 10% owner Soleus Capital Group, LLC — 10% owner | Purchase (P): 375,000 @ $20 · Purchase (P): 125,000 @ $20 · Conversion (C): 527,070 @ $9.48 · Conversion (C): 527,070 (derivative) @ $0 | EDGAR |
| 2026-06-16 | 4 | SEBULSKY ALAN — Director | Purchase (P): 8,435 @ $27.67 · Purchase (P): 5,000 @ $26.00 · Purchase (P): 4,065 @ $27.10 | EDGAR |
| 2026-06-15 | 4 | Borisy Alexis — Director | Conversion (C): 105,414 · Conversion (C): 162,221 (derivative) | EDGAR |
| 2026-06-15 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Conversion (C): 6,556,740 · Conversion (C): 1,187,881 · Purchase (P): 19,728,353 @ $20 · Purchase (P): 1,460,397 @ $20 · Conversion (C): 642,250 (derivative) · Conversion (C): 160,562 (derivative) · +2 more | EDGAR |
| 2026-06-15 | 4 | FITZGERALD EDWARD M — Director | Conversion (C): 5,539 · Conversion (C): 3,878 · Conversion (C): 5,271 · Conversion (C): 5,332 (derivative) · Conversion (C): 3,666 (derivative) · Conversion (C): 8,111 (derivative) | EDGAR |
| 2026-06-15 | 4 | SEBULSKY ALAN — Director | Purchase (P): 12,500 @ $20 | EDGAR |
| 2026-06-11 | 4 | Weber Barbara — Director | Grant/award (A): 20,215 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Simson Jake — Director | Grant/award (A): 20,215 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Klausner Richard — Director | Grant/award (A): 20,215 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Yeshwant Krishna — Director | Grant/award (A): 20,215 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Borisy Alexis — Director | Grant/award (A): 20,215 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director RA Capital Healthcare Fund LP — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director Shah Rajeev M. — Director | Grant/award (A): 20,215 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | FITZGERALD EDWARD M — Director | Grant/award (A): 20,215 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | SEBULSKY ALAN — Director | Grant/award (A): 39,792 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Flynn James E — 10% owner Deerfield Mgmt HIF, L.P. — 10% owner DEERFIELD MANAGEMENT COMPANY, L.P. — 10% owner Deerfield Healthcare Innovations Fund, L.P. — 10% owner Deerfield Mgmt III, L.P. — 10% owner Deerfield Private Design Fund III, L.P. — 10% owner | Conversion (C): 122,990 · Conversion (C): 122,990 · Conversion (C): 149,238 · Conversion (C): 149,238 · Conversion (C): 260,992 · Conversion (C): 260,992 · +10 more | EDGAR |
Recent 8-K events — Parabilis Medicines, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-15 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
| 2026-09-02 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-08-25 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-11 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=PBLS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →